Merçé Boada

39.9k citations
225 papers · 7.7k · 5 hit papers · h-index 44

Impact in

    • Tryptophan and brain disorders
  • Neurology top 0.5%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Intracerebral and Subarachnoid Hemorrhage Research

Papers in

Merçé Boada

207 papers receiving 7.5k citations

Merçé Boada's Hit Papers

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint 2023 · 82 citations
820+7+15Years since publication2505007501000

Peers

Merçé Boada
Comparison fields: 5 of 145
  • Biological Psychiatry 432
  • Neurology 1.2k
  • Physiology 3.5k
  • Psychiatry and Mental health 1.5k
  • Pharmacology 1.1k
Replace Marwan N. Sabbagh with:
Marwan N. Sabbagh United States
Patrick G. Kehoe United Kingdom
Niels Andreasen Sweden
Alberto Lleó Spain
Kwasi G. Mawuenyega United States
Hans Basun Sweden
Christiane Reitz United States
Erik Portelius Sweden
Judes Poirier Canada
Meng‐Shan Tan China
Merçé Boada relative to Marwan N. Sabbagh United States Marwan N. Sabbagh's profile →
Citations per field
00.5×1.5×
Marwan N. Sabbagh · 1×
Citations per year

Countries citing papers authored by Merçé Boada

Since Specialization
Citations

This map shows the geographic impact of Merçé Boada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merçé Boada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merçé Boada more than expected).

Fields of papers citing papers by Merçé Boada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merçé Boada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merçé Boada. The network helps show where Merçé Boada may publish in the future.

Co-authors

The 25 scholars most cited alongside Merçé Boada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Merçé Boada Line = papers co-authored together Merçé Boada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Hit paper breakdown →
20031060
2 2004468
3
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Hit paper breakdown →
2017417
4
A Phase II Trial of Tideglusib in Alzheimer's Disease
Hit paper breakdown →
2015417
5
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
Hit paper breakdown →
2019392
6 2013135
7 2020131
8 2020127
9
[Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)].
2003106
10 2020102
11 2019100
12 200992
13 201886
14 202182
15 200682
16 201982
17
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Hit paper breakdown →
202382
18 202381
19 201680
20 201978

About Merçé Boada

Merçé Boada is a scholar working on Psychiatry and Mental health, Physiology, Molecular Biology, Neurology and Neurology, having authored 225 papers that have together received 7.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (73 papers), Alzheimer's disease research and treatments (73 papers), Cholinesterase and Neurodegenerative Diseases (11 papers), S100 Proteins and Annexins (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Health, Environment, Cognitive Aging (7 papers), Computational Drug Discovery Methods (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). The work is most often cited by research in Biological Psychiatry (432 citations), Neurology (1.2k citations), Physiology (3.5k citations), Psychiatry and Mental health (1.5k citations) and Pharmacology (1.1k citations). Merçé Boada has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Bruno Dubois, Agustı́n Ruiz, Lluís Tárraga, Isidró Ferrer, María Rey, Montserrat Alegret, B. Laurent, S. Gilman, Bernard‐François Michel and C. Hock. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, Alzheimer s Research & Therapy, The Journal of Prevention of Alzheimer s Disease and Neurobiology of Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact